We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs, Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Daily Bulletin
    • Drug Industry Daily
  • Device News
    • Trending
    • Commercial Operations
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Daily Bulletin
    • FDAnews Device Daily Bulletin Premium
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Drug Books » The Revised ICH E8: A Guide to New Clinical Trial Requirements

Other Options

PDF Edition

$397.00

PDF Edition - 3-4 Copies (10% Off)

$357.00

PDF Edition - 5-6 Copies (15% Off)

$337.00

PDF Edition - 7-9 Copies (20% Off)

$317.00

PDF Edition - 10+ Copies (25% Off)

$217.00
The Revised ICH E8: A Guide to New Clinical Trial Requirements

The Revised ICH E8: A Guide to New Clinical Trial Requirements

$397.00
Devices

Product Details

“The quality by design approach to clinical research (section 3.1) involves focusing on critical to quality factors to ensure the protection of study subjects, the generation of reliable and meaningful results, and the management of risks to those factors (section 3.2).”

— General Considerations for Clinical Studies E8(R1)

With ICH E8(R1) adopted, your planning, design and conduct of clinical trials looks different. Make sure you’re ready to implement the new guidelines.

The Revised ICH E8: A Guide to New Clinical Trial Requirements management reportexplains the ICH E8 updates and guides you through assessing the impact of key concepts on current and future clinical development practices, including the framework and approaches for identifying quality-by-design and critical-to-quality factors. The report reviews these and other expectations:

  • The scope and general principles of the ICH E8(R1) guideline
  • The impact on current research practices and influences on SOPs, procedures, processes and documentation
  • The framework and approaches for identifying critical-to-quality factors
  • Clinical development areas that may be impacted by the adoption of the ICH E8(R1) guideline and approaches for compliance

Prepare for ICH E8(R1) now.

About the Contributor

Leslie Sam is Principal Consultant, Wool Consulting Group, supporting the development and refinement of clinical quality management systems, issue management and clinical trial risk management in clinical research. She is an accomplished, results-driven and passionate clinical research and quality professional with 20+ years of transferable technical and leadership skills and business acumen. Ms. Sam has Six Sigma Black Belt certification (CSSBB) and Quality Improvement Associate certification issued by the American Society for Quality. She is co-author of three TransCelerate Group peer-reviewed journal articles on the topics of clinical quality management systems and issues management systems.

Who Will Benefit

  • Regulatory Affairs Professionals
  • Clinical Operations Personnel
  • Project Managers
  • Quality Professionals
  • Compliance Professionals
  • Clinical Development Professionals

PDF

$397.00
Add to Cart

Contributor:
Leslie Sam

ISBN-13:
978-1-60430-122-9

Publication date:
March 2019

Page count:
99

Multi-user Access
Save money with a license agreement allowing significant numbers of users access to an electronic version of this book. For multi-user access to multiple titles, FDAnews offers the FDAnews Books Library — a personalized collection of FDAnews publications that is fully searchable. Contact Customer Service for a quote or more information.


Our Guarantee
Not satisfied with your publication? For the PDF version, you must notify FDAnews within 24 hours of receipt of purchase and we will refund 100 percent of your purchase price.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing